NEW YORK--(BUSINESS WIRE)--Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the Credit Suisse Annual
Health Care Conference on Wednesday, November 14, 2018 in Scottsdale,
AZ. Chris Boerner, chief commercial officer, will answer questions about
the company at 8 a.m. MT (10 a.m. ET).
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb CompanyMedia:Lisa McCormick Lavery, 609-252-7602 lisa.mccormicklavery@bms.com orInvestors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com